drugset / Trial / NCT00006018
Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
5 enrolled
Case Comprehensive Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of paclitaxel and BMS-214662 in treating patients who have advanced solid tumors.
Timeline
- Start
- 2000-07
- Primary completion
- 2001-12
- Completion
- 2002-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-214662 | Small molecule | — | Intravenous |
| Background | Paclitaxel | Small molecule | — | Intravenous |